Immunome News

Immunome | 4: Statement of changes in beneficial ownership of securities-Director BIENAIME JEAN JACQUES

May 22 16:56 ET

Immunome | 4: Statement of changes in beneficial ownership of securities-Officer SIEGALL CLAY B

May 21 16:16 ET

Immunome | 4: Statement of changes in beneficial ownership of securities-Officer Rosett Max

May 17 17:14 ET

Immunome | 424B5: Prospectus

May 14 08:49 ET

Immunome | 10-Q: Quarterly report

May 14 08:09 ET

Immunome | 8-K: Immunome Reports First Quarter 2024 Financial Results and Provides Business Update

May 14 08:04 ET

Immunome | 8-K: Current report

Apr 30 16:10 ET

Immunome | 4: Statement of changes in beneficial ownership of securities-Director SWAIN SANDRA M

Apr 29 20:19 ET

Immunome | 3: Initial statement of beneficial ownership of securities-Director SWAIN SANDRA M

Apr 29 20:15 ET

Immunome | ARS: Annual Report to Security Holders

Apr 26 16:33 ET

Immunome | DEFA14A: Others

Apr 26 16:18 ET

Immunome | DEF 14A: Definitive information statements

Apr 26 16:11 ET

Immunome | 8-K: Current report

Apr 25 16:06 ET

Immunome | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Apr 3 16:45 ET

Immunome | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Apr 3 16:42 ET

Immunome | 8-K: Current report

Mar 28 16:13 ET

Immunome | 10-K: Annual report

Mar 28 16:12 ET

Immunome | 8-K: Current report

Mar 26 08:09 ET

Immunome | 4: Statement of changes in beneficial ownership of securities-Officer Horn Kinney

Feb 21 21:12 ET

Immunome | 3: Initial statement of beneficial ownership of securities-Officer Horn Kinney

Feb 21 21:12 ET